Schedule 13G ownership disclosure

PAVMED INC

Common Stock, Par Value $0.001 Per Share · CUSIP: 70387R403

Event date: 2025-02-21

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Tasso Partners, LLC

    Shares: 2,574,350.00 · Class: 18.9%

  • Dana Carrera

    Shares: 2,574,350.00 · Class: 18.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001094891-25-000002
Form type
SCHEDULE 13G
Filer
PAVmed Inc.
CIK
CIK 1624326
Filed
Feb 28, 2025
Reporting period
Feb 21, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub